Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
The Quest for a Safer Alternative to Viral Gene Therapy Continues
Author Affiliations & Notes
  • Pawan K Shahi
    Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Meha Kabra
    Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Bikash R Pattnaik
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
    Pediatrics, Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Pawan Shahi, None; Meha Kabra, None; Bikash Pattnaik, None
  • Footnotes
    Support  NIHEY024995
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pawan K Shahi, Meha Kabra, Bikash R Pattnaik; The Quest for a Safer Alternative to Viral Gene Therapy Continues. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Viral vector-mediated Gene therapy is at the forefront of the treatment for inherited and acquired retinal disorders. The eye provides a tight blood-brain barrier, low antigenicity to the viruses, and ease of surgical access. Retinal Pigment epithelium (RPE) cells are one of the primary targets for gene therapy. A combination of the cell-specific promoter and lentiviruses, adeno-associated virus (AAV)5, or AAV7m8 successfully transduces RPE cells in vivo. We sought to evaluate RPE cells' immune response after viral gene delivery by subretinal injections.

Methods : 6 weeks old C57Bl6 wild type mice were injected with Lentivirus, AAV5, or AAV7m8 carrying GFP reporter gene driven by CMV promoter via subretinal injection. After 7 or 14 days of injection, the mice were sacrificed, and the eyes were enucleated. The RPE florets were imaged for GFP fluorescence expression using the confocal microscope to confirm the transduction. RPE cells were later dissociated, mRNA was isolated and converted to cDNA. These were subjected to qPCR using the primers for IFNγ, IL-1α, IL-1β, IL-6, CD-8, and Iba-1 immunogenic markers.

Results : IFNγ, an activator of macrophages, and IL-1α, an inflammatory cytokine, were not detected in RPE cells after the viral gene delivery. The expression of IL-6, another pro-inflammatory cytokine, was negligible at week 1, being marginally higher in the lentiviral injected eye relative to both AAV7m8 and AAV5. The expression of IL-6 subsequently decreased at week 2. Expression of IL1β cytokine was profound in the week 1 sample. Its expression in the lentiviral injected eye was 2-fold higher than AAV7m8, or AAV5, which was abolished entirely at week 2. CD-8 transcripts were 2.7-fold higher for lentiviral and 5.2 fold higher for AAV7m8 compared to AAV5 mediated gene delivery. Its expression persisted at week 2. The expression of Iba-1, a microglia marker, was significantly higher with a 2-fold higher presence for AAVs compared to lentivirus. Its upregulation continued in the AAV7m8 injected eye at week 2. We did not detect any of the above cytokines in the PBS injected control eyes.

Conclusions : Our results indicate that transduced RPE cells by subretinal delivery of viruses elicited inflammatory cytokines. The extent of cellular toxicity in the RPE was greater for AAVs compared to lentivirus. It might be beneficial to consider adjunct immune suppressor therapy for the viral-mediated delivery or use non-viral modalities.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×